Literature DB >> 2422398

Passive protection against rotavirus-induced diarrhea by monoclonal antibodies to surface proteins vp3 and vp7.

P A Offit, R D Shaw, H B Greenberg.   

Abstract

Monoclonal antibodies directed against two rotavirus surface proteins (vp3 and vp7) as well as a rotavirus inner capsid protein (vp6) were tested for their ability to protect suckling mice against virulent rotavirus challenge. Monoclonal antibodies to two distinct epitopes of vp7 of simian rotavirus strain RRV neutralized RRV in vitro and passively protected suckling mice against RRV challenge. A monoclonal antibody directed against vp3 of porcine rotavirus strain OSU neutralized three distinct serotypes in vitro (OSU, RRV, and UK) and passively protected suckling mice against OSU, RRV, and UK virus-induced diarrhea. The role of vp3 in eliciting protection against heterotypic rotavirus challenge should be considered when developing a vaccine with cloned rotavirus genes. Alternatively, immunization with a reassortant rotavirus containing vp3 and vp7 from two antigenically distinct rotavirus parents might protect against diarrhea induced by two or more rotavirus serotypes.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2422398      PMCID: PMC252967     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  36 in total

1.  THE PREPARATION OF I-131-LABELLED HUMAN GROWTH HORMONE OF HIGH SPECIFIC RADIOACTIVITY.

Authors:  F C GREENWOOD; W M HUNTER; J S GLOVER
Journal:  Biochem J       Date:  1963-10       Impact factor: 3.857

2.  Rotaviral immunity in gnotobiotic calves: heterologous resistance to human virus induced by bovine virus.

Authors:  R G Wyatt; C A Mebus; R H Yolken; A R Kalica; H D James; A Z Kapikian; R M Chanock
Journal:  Science       Date:  1979-02-09       Impact factor: 47.728

3.  Determination of the number of nonoverlapping antigenic areas on Hong Kong (H3N2) influenza virus hemagglutinin with monoclonal antibodies and the selection of variants with potential epidemiological significance.

Authors:  R G Webster; W G Laver
Journal:  Virology       Date:  1980-07-15       Impact factor: 3.616

4.  Genes of human (strain Wa) and bovine (strain UK) rotaviruses that code for neutralization and subgroup antigens.

Authors:  A R Kalica; H B Greenberg; R G Wyatt; J Flores; M M Sereno; A Z Kapikian; R M Chanock
Journal:  Virology       Date:  1981-07-30       Impact factor: 3.616

5.  Antigenic comparisons of two new rotaviruses from rhesus monkeys.

Authors:  G Stuker; L S Oshiro; N J Schmidt
Journal:  J Clin Microbiol       Date:  1980-02       Impact factor: 5.948

6.  Selective primary health care: an interim strategy for disease control in developing countries.

Authors:  J A Walsh; K S Warren
Journal:  N Engl J Med       Date:  1979-11-01       Impact factor: 91.245

7.  Monoclonal antibodies against rabies virus produced by somatic cell hybridization: detection of antigenic variants.

Authors:  T J Wiktor; H Koprowski
Journal:  Proc Natl Acad Sci U S A       Date:  1978-08       Impact factor: 11.205

8.  Importance of a new virus in acute sporadic enteritis in children.

Authors:  G P Davidson; R F Bishop; R R Townley; I H Holmes
Journal:  Lancet       Date:  1975-02-01       Impact factor: 79.321

9.  Plaque assay of neonatal calf diarrhea virus and the neutralizing antibody in human sera.

Authors:  S Matsuno; S Inouye; R Kono
Journal:  J Clin Microbiol       Date:  1977-01       Impact factor: 5.948

10.  A two-year study of bacterial, viral, and parasitic agents associated with diarrhea in rural Bangladesh.

Authors:  R E Black; M H Merson; A S Rahman; M Yunus; A R Alim; I Huq; R H Yolken; G T Curlin
Journal:  J Infect Dis       Date:  1980-11       Impact factor: 5.226

View more
  91 in total

1.  Evaluation of a latex agglutination kit (Virogen Rotatest) for detection of bovine rotavirus in fecal samples.

Authors:  Y Al-Yousif; J Anderson; C Chard-Bergstrom; A Bustamante; M Muenzenberger; K Austin; S Kapil
Journal:  Clin Diagn Lab Immunol       Date:  2001-05

2.  Serotypic characterization of group A rotaviruses associated with children's diarrhea in Slovakia.

Authors:  J Tietzová; A Petrovicová
Journal:  Folia Microbiol (Praha)       Date:  2000       Impact factor: 2.099

3.  Specific interactions between rotavirus outer capsid proteins VP4 and VP7 determine expression of a cross-reactive, neutralizing VP4-specific epitope.

Authors:  D Y Chen; M K Estes; R F Ramig
Journal:  J Virol       Date:  1992-01       Impact factor: 5.103

4.  Comparisons of rotavirus VP7-typing monoclonal antibodies by competition binding assay.

Authors:  P Raj; D O Matson; B S Coulson; R F Bishop; K Taniguchi; S Urasawa; H B Greenberg; M K Estes
Journal:  J Clin Microbiol       Date:  1992-03       Impact factor: 5.948

5.  Isolation and characterization of a novel reassortant between avian Ty-1 and simian RRV rotaviruses.

Authors:  D A Kool; S M Matsui; H B Greenberg; I H Holmes
Journal:  J Virol       Date:  1992-11       Impact factor: 5.103

6.  SA-11 rotavirus binding to human serum lipoproteins.

Authors:  F Superti; L Seganti; M Marchetti; M L Marziano; N Orsi
Journal:  Med Microbiol Immunol       Date:  1992       Impact factor: 3.402

7.  Structural rearrangements in the membrane penetration protein of a non-enveloped virus.

Authors:  Philip R Dormitzer; Emma B Nason; B V V Prasad; Stephen C Harrison
Journal:  Nature       Date:  2004-08-26       Impact factor: 49.962

8.  Isolation of human monoclonal antibodies that neutralize human rotavirus.

Authors:  Kyoko Higo-Moriguchi; Yasushi Akahori; Yoshitaka Iba; Yoshikazu Kurosawa; Koki Taniguchi
Journal:  J Virol       Date:  2004-04       Impact factor: 5.103

9.  Reactivity of VP4-specific monoclonal antibodies to a serotype 4 porcine rotavirus with distinct serotypes of human (symptomatic and asymptomatic) and animal rotaviruses.

Authors:  S Y Kang; L J Saif; K L Miller
Journal:  J Clin Microbiol       Date:  1989-12       Impact factor: 5.948

10.  Role of immunoglobulin A in protection against reovirus entry into Murine Peyer's patches.

Authors:  K J Silvey; A B Hutchings; M Vajdy; M M Petzke; M R Neutra
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.